Symphony Financial Ltd. Co. raised its holdings in shares of CVS Health Co. (NYSE:CVS) by 15.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 4,643 shares of the pharmacy operator’s stock after acquiring an additional 607 shares during the period. Symphony Financial Ltd. Co.’s holdings in CVS Health were worth $325,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the stock. KMG Fiduciary Partners LLC grew its position in CVS Health by 16.4% during the fourth quarter. KMG Fiduciary Partners LLC now owns 60,950 shares of the pharmacy operator’s stock worth $4,295,000 after buying an additional 8,609 shares in the last quarter. First Citizens Bank & Trust Co. grew its position in CVS Health by 5.9% during the fourth quarter. First Citizens Bank & Trust Co. now owns 34,073 shares of the pharmacy operator’s stock worth $2,328,000 after buying an additional 1,904 shares in the last quarter. Xcel Wealth Management LLC lifted its stake in CVS Health by 0.7% during the fourth quarter. Xcel Wealth Management LLC now owns 32,140 shares of the pharmacy operator’s stock worth $2,195,000 after purchasing an additional 222 shares during the last quarter. Cox Capital Mgt LLC lifted its stake in CVS Health by 3.6% during the fourth quarter. Cox Capital Mgt LLC now owns 43,892 shares of the pharmacy operator’s stock worth $2,998,000 after purchasing an additional 1,527 shares during the last quarter. Finally, Foundations Investment Advisors LLC bought a new stake in CVS Health during the fourth quarter worth about $610,000. Institutional investors and hedge funds own 74.21% of the company’s stock.

In related news, EVP Lisa Bisaccia sold 25,177 shares of the firm’s stock in a transaction on Tuesday, January 12th. The stock was sold at an average price of $77.00, for a total value of $1,938,629.00. Following the transaction, the executive vice president now directly owns 71,765 shares of the company’s stock, valued at approximately $5,525,905. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Alan Lotvin sold 7,138 shares of the firm’s stock in a transaction on Friday, November 13th. The stock was sold at an average price of $70.00, for a total value of $499,660.00. Following the completion of the transaction, the executive vice president now directly owns 8,023 shares in the company, valued at $561,610. The disclosure for this sale can be found here. Insiders have sold a total of 58,151 shares of company stock worth $4,375,989 over the last three months. Insiders own 0.46% of the company’s stock.

CVS has been the subject of a number of recent analyst reports. Piper Sandler upped their price target on CVS Health from $72.00 to $76.00 and gave the company an “overweight” rating in a research report on Wednesday, November 11th. Jefferies Financial Group raised CVS Health from a “hold” rating to a “buy” rating and set a $90.00 price target for the company in a research report on Friday, January 8th. SVB Leerink upped their price target on CVS Health from $73.00 to $80.00 and gave the company a “market perform” rating in a research report on Monday, December 14th. BidaskClub raised CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 7th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a report on Monday, November 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. CVS Health has a consensus rating of “Buy” and a consensus target price of $82.93.

NYSE CVS opened at $74.92 on Thursday. The business’s fifty day moving average price is $70.55 and its 200-day moving average price is $64.33. The stock has a market capitalization of $98.06 billion, a price-to-earnings ratio of 12.38, a PEG ratio of 1.69 and a beta of 0.82. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.67. CVS Health Co. has a 1-year low of $52.04 and a 1-year high of $77.23.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, November 11th. The pharmacy operator reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.33. The firm had revenue of $67.05 billion for the quarter, compared to analysts’ expectations of $66.54 billion. CVS Health had a return on equity of 15.60% and a net margin of 2.99%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.84 EPS. Equities research analysts anticipate that CVS Health Co. will post 7.43 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, February 1st. Stockholders of record on Friday, January 22nd will be issued a dividend of $0.50 per share. The ex-dividend date is Thursday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.67%. CVS Health’s payout ratio is 28.25%.

CVS Health Profile

CVS Health Corporation provides health services and plans in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services.

See Also: What is meant by buying and selling pressure?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.